If you weren't able to attend live I think it's worth catching up on this really interesting webinar by the Baker McKenzie Healthcare and Life Sciences Industry Group on evolving compulsory licensing regimes and how they are being shaped by the pandemic.
With the mounting global pressure to secure vaccines in development and drugs showing promise as possible COVID-19 treatments, our speakers shared practical insights and updates on the compulsory licensing trends and regulations likely to affect companies across Asia Pacific; Europe, the Middle East and Africa; Latin America*; and North America.
